go 6976 has been researched along with Cancer of Nasopharynx in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, Z | 1 |
| Xu, S | 1 |
| Liu, M | 1 |
| Zeng, YX | 1 |
| Kang, T | 1 |
1 other study available for go 6976 and Cancer of Nasopharynx
| Article | Year |
|---|---|
Chk1 inhibitor Gö6976 enhances the sensitivity of nasopharyngeal carcinoma cells to radiotherapy and chemotherapy in vitro and in vivo.
Topics: Animals; Carbazoles; Cell Cycle; Cell Line, Tumor; Checkpoint Kinase 1; Cisplatin; Drug Synergism; H | 2010 |